Baxter
BAX
#1053
Rank
$17.32 B
Marketcap
$34.00
Share price
0.80%
Change (1 day)
-24.34%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Revenue for Baxter (BAX)

Revenue in 2023 (TTM): $14.94 B

According to Baxter's latest financial reports the company's current revenue (TTM) is $14.89 B. In 2022 the company made a revenue of $14.79 B an increase over the years 2021 revenue that were of $12.78 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Baxter from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) $14.94 B1.03%
2022 $14.79 B15.75%
2021 $12.78 B9.52%
2020 $11.67 B2.74%
2019 $11.36 B2.17%
2018 $11.12 B5.3%
2017 $10.56 B3.92%
2016 $10.16 B1.96%
2015 $9.96 B-34.35%
2014 $15.18 B-0.08%
2013 $15.19 B7.08%
2012 $14.19 B2.14%
2011 $13.89 B8.18%
2010 $12.84 B2.24%
2009 $12.56 B1.73%
2008 $12.34 B9.63%
2007 $11.26 B8.53%
2006 $10.37 B5.37%
2005 $9.84 B3.58%
2004 $9.50 B6.66%
2003 $8.91 B10.95%
2002 $8.03 B4.85%
2001 $7.66 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$32.32 B 117.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$42.49 B 185.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.71 B 32.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.70 B-1.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.96 B 40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$220.57 B 1,381.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.25 B-84.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.86 B-94.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.42 B-30.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.29 B-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA